Search Result

Results for "

MT

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (13) Adrenergic Receptor (2) AMPK (1) Antibiotic (3) Apoptosis (8) Bacterial (8) Btk (1) Carbonic Anhydrase (1) CD3 (1) CXCR (3) Cytochrome P450 (1) DNA Methyltransferase (1) DNA/RNA Synthesis (1) Drug Metabolite (2) EBV (1) Endogenous Metabolite (7) Epigenetic Reader Domain (1) Ferroptosis (1) Hippo (MST) (1) HIV (30) HIV Integrase (2) HIV Protease (1) Influenza Virus (1) IRAK (1) Isotope-Labeled Compounds (4) LPL Receptor (2) mAChR (1) Melanocortin Receptor (4) Melatonin Receptor (31) Microtubule/Tubulin (6) Mineralocorticoid Receptor (2) MMP (1) mTOR (1) Myosin (1) Opioid Receptor (2) P2X Receptor (1) Parasite (3) Phosphodiesterase (PDE) (1) PKC (1) PPAR (2) Prostaglandin Receptor (2) PROTAC Linkers (1) PROTACs (2) Reactive Oxygen Species (1) Reverse Transcriptase (3) SARS-CoV (2) Sigma Receptor (1) Small Interfering RNA (siRNA) (26) Sodium Channel (1) TGF-β Receptor (1) Trk Receptor (1) TRP Channel (2)
By Research Areas:	Cancer (40) Cardiovascular Disease (8) Endocrinology (13) Infection (42) Inflammation/Immunology (9) Metabolic Disease (10) Neurological Disease (40)
Click Chemistry:	Alkynes (1)
Oligonucleotides:	Pre-designed siRNA Sets (26) CpG ODNs (2) siRNAs (26)

147

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-128595

MT-4	Others	Cancer
MT-4 blocks the TG2/FN complex at the interface between cancer cells and the tumor niche. MT-4 inhibits the adhesion of ovarian cancer (OC) cells to the peritoneum .

HY-122562

MT-802 2 Publications Verification	PROTACs Btk	Inflammation/Immunology Cancer
MT-802 is a potent BTK degrader based on Cereblon ligand, with a DC₅₀ of 1 nM. MT-802 has potential to treat C481S mutant chronic lymphocytic leukemia (CLL) .

HY-162677

MT-1207	Adrenergic Receptor 5-HT Receptor	Cardiovascular Disease
MT-1207 is an orally active and selective adrenergic α₁ and 5-HT_2A receptor antagonist. MT-1207 shows IC₅₀<0.1 nM, 0.15 nM, 1.40 nM and 0.27 nM for α_1A, α_1B, α_1D and 5-HT_2A, respectively. MT-1207 achieves an effective blood pressure (BP) reduction in the 2K2C rat model without damaging renal function. MT-1207 is a potent multitarget inhibitor with the potential for vasodilatation research .

HY-128932

Cefminox sodium 1 Publications Verification MT-141	Bacterial PPAR Prostaglandin Receptor Antibiotic	Infection Cardiovascular Disease Endocrinology
Cefminox sodium (MT-141) is a semisynthetic cephamycin, which exhibits a broad spectrum of antibacterial activity . Cefminox sodium (MT-141) also acts as a dual agonist of prostacyclin receptor (IP) and PPARγ, upregulates cAMP production and PTEN expression and inhibits Akt/mTOR signaling. Cefminox sodium (MT-141) also prevents pulmonary arterial hypertension .

HY-W058849

MT 63-78	AMPK mTOR Apoptosis	Cancer
MT 63-78 is a specific and potent direct AMPK activator with an EC₅₀ of 25 μM. MT 63–78 also induces cell mitotic arrest and apoptosis. MT 63-78 blocks prostate cancer growth by inhibiting the lipogenesis and mTORC1 pathways. MT 63-78 has antitumor effects .

HY-109087

Elismetrep MT-8554	TRP Channel	Neurological Disease
Elismetrep (MT-8554) is an oral active TRPM8 inhibitor, and can be used for study of analgesic .

HY-109002

Apararenone MT-3995	Mineralocorticoid Receptor	Cardiovascular Disease Metabolic Disease
Apararenone (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis.

HY-122249

MT-7	Microtubule/Tubulin	Cancer
MT-7 is a potent mitotic inhibitor. MT-7 shows antiproliferative activity. MT-7 induces cell cycle arrest at G2/M phase. MT-7 induces specific, reversible mitotic arrest and inhibits the polymerization of cellular microtubules .

HY-141810

MT-134	Myosin	Others
MT-134 is a SkMII-specific inhibitor and has excellent exposure in muscles.

HY-122241

MT477	PKC	Cancer
MT477 is a potent protein kinase C (PKC) inhibitor. MT477 induces apoptosis and necrosis. MT477 decreases the protein expression of Ras-GTP, p-Erk1/2, p-Elk1. MT477 shows antitumor activity .

HY-147277

Lorundrostat MT-4129	Mineralocorticoid Receptor	Cardiovascular Disease
Lorundrostat (MT-4129) is an orally active aldosterone synthase inhibitor. Lorundrostat can be used in studies of high blood pressure .

HY-128349

MT-3014	Phosphodiesterase (PDE)	Neurological Disease
MT-3014 is a potent, highly selective and brain-penetrated phosphodiesterase 10A (PDE 10A) inhibitor, with IC₅₀s of 0.062 nM and 0.09 nM for human PDE 10A and bovine PDE 10A, respectively .

HY-107094

MT-7716 hydrochloride W-212393 hydrochloride	Opioid Receptor	Neurological Disease
MT-7716 hydrochloride (W-212393 hydrochloride) is a selective non-peptide nociceptin receptor (NOP) agonist and promising potential treatment drug for alcohol abuse and relapse prevention .

HY-111976

MT1	Epigenetic Reader Domain	Cancer
MT1 is a bivalent chemical probe of BET bromodomains, with an IC₅₀ of 0.789 nM for BRD4(1) .

HY-16734

Amiselimod MT-1303	LPL Receptor	Inflammation/Immunology
Amiselimod (MT-1303) is a modulator for sphingosine 1-phosphate receptor (S1P receptor). Amiselimod converses to its active metabolite (S)-amiselimod phosphate by sphingosine kinases (SPHKs), targets S1P1 receptor, ameliorates the autoimmune disease without causing bradycardia .

HY-107094A

MT-7716 free base W-212393	Opioid Receptor	Neurological Disease
MT-7716 free base (W-212393) is a selective non-peptide nociceptin receptor (NOP) agonist and promising potential treatment drug for alcohol abuse and relapse prevention .

HY-125161

MT0703	Others	Others
MT0703 is an aminothiazolyl glycyl cephalosporin with a 1,5-dihydroxy-4-pyridone-2-carbonyl group and has good anti-Pseudomonas activity.

HY-147006

Zovodotin MT-VC-ZD02044	Others	Cancer
MT-VC-ZD02044 is a cytotoxic and anti-mitotic agent .

HY-146299

Mt KARI-IN-2	Bacterial	Infection
Mt KARI-IN-2 (compound 5b) is a potent Mycobacterium tuberculosis ketol-acid reductoisomerase (Mtb KARI) inhibitor with a K_i value of 2.02 μM. Mt KARI-IN-2 has inhibitory activity against Mtb H37Rv (MIC = 0.78 μM) and low cytotoxicity (HEK IC₅₀ > 86 μg/mL) .

HY-146300

Mt KARI-IN-4	Bacterial	Infection
Mt KARI-IN-4 (compound 5c) is a potent Mycobacterium tuberculosis ketol-acid reductoisomerase (Mtb KARI) inhibitor with a K_i value of 5.48 μM. Mt KARI-IN-4 has inhibitory activity against Mtb H37Rv (MIC = 0.78 μM) and low cytotoxicity (HEK IC₅₀ > 72 μg/mL) .

HY-146301

Mt KARI-IN-5	Bacterial	Infection
Mt KARI-IN-5 (compound 6c) is a potent Mycobacterium tuberculosis ketol-acid reductoisomerase (Mtb KARI) inhibitor with a K_i value of 4.72 μM. Mt KARI-IN-5 has inhibitory activity against Mtb H37Rv (MIC = 1.56 μM) and low cytotoxicity (HEK IC₅₀ > 64 μg/mL)

HY-RS08744

MT3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT3 Human Pre-designed siRNA Set A contains three designed siRNAs for MT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT3 Human Pre-designed siRNA Set A MT3 Human Pre-designed siRNA Set A

HY-RS08745

MT4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT4 Human Pre-designed siRNA Set A contains three designed siRNAs for MT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT4 Human Pre-designed siRNA Set A MT4 Human Pre-designed siRNA Set A

HY-RS08761

MT-CYB Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-CYB Human Pre-designed siRNA Set A contains three designed siRNAs for MT-CYB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-CYB Human Pre-designed siRNA Set A MT-CYB Human Pre-designed siRNA Set A

HY-109114

Dersimelagon MT-7117	Melanocortin Receptor	Metabolic Disease
Dersimelagon (MT-7117) is an orally active, selective melanocortin 1 receptor (MC1R) agonist with EC₅₀ values of 8.16, 3.91, 1.14 and 0.251 nM for human (h), cynomolgus monkey (cm), mouse (m) and rat (r) MC1R, respectively. Dersimelagon shows good affinity for hMC1R and hMC4R with K_i values of 2.26, 32.9 nM, respectively. Dersimelagon can be used for the research of skin pigmentation .

HY-146298

Mt KARI-IN-1	Bacterial	Infection
Mt KARI-IN-1 (Lead compound) is a potent Mycobacterium tuberculosis ketol-acid reductoisomerase (Mtb KARI) inhibitor with a K_i value of 3.06 μM .

HY-RS08735

MT1A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT1A Human Pre-designed siRNA Set A contains three designed siRNAs for MT1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT1A Human Pre-designed siRNA Set A MT1A Human Pre-designed siRNA Set A

HY-RS08743

MT2A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT2A Human Pre-designed siRNA Set A contains three designed siRNAs for MT2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT2A Human Pre-designed siRNA Set A MT2A Human Pre-designed siRNA Set A

HY-RS08736

MT1B Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT1B Human Pre-designed siRNA Set A contains three designed siRNAs for MT1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT1B Human Pre-designed siRNA Set A MT1B Human Pre-designed siRNA Set A

HY-RS08737

MT1E Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT1E Human Pre-designed siRNA Set A contains three designed siRNAs for MT1E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT1E Human Pre-designed siRNA Set A MT1E Human Pre-designed siRNA Set A

HY-RS08738

MT1F Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT1F Human Pre-designed siRNA Set A contains three designed siRNAs for MT1F gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT1F Human Pre-designed siRNA Set A MT1F Human Pre-designed siRNA Set A

HY-RS08739

MT1G Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT1G Human Pre-designed siRNA Set A contains three designed siRNAs for MT1G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT1G Human Pre-designed siRNA Set A MT1G Human Pre-designed siRNA Set A

HY-RS08740

MT1H Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT1H Human Pre-designed siRNA Set A contains three designed siRNAs for MT1H gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT1H Human Pre-designed siRNA Set A MT1H Human Pre-designed siRNA Set A

HY-RS08741

MT1M Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT1M Human Pre-designed siRNA Set A contains three designed siRNAs for MT1M gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT1M Human Pre-designed siRNA Set A MT1M Human Pre-designed siRNA Set A

HY-RS08742

MT1X Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT1X Human Pre-designed siRNA Set A contains three designed siRNAs for MT1X gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT1X Human Pre-designed siRNA Set A MT1X Human Pre-designed siRNA Set A

HY-RS08751

MT-ATP6 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ATP6 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ATP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ATP6 Human Pre-designed siRNA Set A MT-ATP6 Human Pre-designed siRNA Set A

HY-RS08752

MT-ATP8 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ATP8 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ATP8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ATP8 Human Pre-designed siRNA Set A MT-ATP8 Human Pre-designed siRNA Set A

HY-RS08757

MT-CO1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-CO1 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-CO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-CO1 Human Pre-designed siRNA Set A MT-CO1 Human Pre-designed siRNA Set A

HY-RS08758

MT-CO2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-CO2 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-CO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-CO2 Human Pre-designed siRNA Set A MT-CO2 Human Pre-designed siRNA Set A

HY-RS08759

MT-CO3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-CO3 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-CO3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-CO3 Human Pre-designed siRNA Set A MT-CO3 Human Pre-designed siRNA Set A

HY-RS08796

MT-ND1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ND1 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ND1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ND1 Human Pre-designed siRNA Set A MT-ND1 Human Pre-designed siRNA Set A

HY-RS08797

MT-ND2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ND2 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ND2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ND2 Human Pre-designed siRNA Set A MT-ND2 Human Pre-designed siRNA Set A

HY-RS08798

MT-ND3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ND3 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ND3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ND3 Human Pre-designed siRNA Set A MT-ND3 Human Pre-designed siRNA Set A

HY-RS08799

MT-ND4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ND4 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ND4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ND4 Human Pre-designed siRNA Set A MT-ND4 Human Pre-designed siRNA Set A

HY-RS08801

MT-ND5 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ND5 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ND5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ND5 Human Pre-designed siRNA Set A MT-ND5 Human Pre-designed siRNA Set A

HY-RS08802

MT-ND6 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ND6 Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ND6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ND6 Human Pre-designed siRNA Set A MT-ND6 Human Pre-designed siRNA Set A

HY-101496

MT-DADMe-ImmA 2 Publications Verification MTDIA; Methylthio-DADMe-Immucillin A	Others	Cancer
MT-DADMe-ImmA is an inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP) with a K_i of 90 pM.

HY-RS08800

MT-ND4L Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MT-ND4L Human Pre-designed siRNA Set A contains three designed siRNAs for MT-ND4L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MT-ND4L Human Pre-designed siRNA Set A MT-ND4L Human Pre-designed siRNA Set A

HY-P5846

Muscarinic toxin 3 MT3	mAChR Adrenergic Receptor	Neurological Disease
Muscarinic toxin 3 (MT3) is a potent and non-competitive mAChR and adrenoceptors antagonist with pIC₅₀s of 6.71, 8.79, 8.86, 7.57, 8.13, 8.49, <6.5, 7.29 against M₁, M₄, α_1A, α_1B, α_1D,α_2A,α_2B and α_2C receptors, respectively. Muscarinic toxin 3 displays prominent adrenoceptor activity .

HY-16734A

Amiselimod hydrochloride MT-1303 hydrochloride	LPL Receptor	Cancer
Amiselimod hydrochloride is an orally active novel sphingosine 1-phosphate receptor-1 (S1P1) modulator, designed to reduce the bradycardia effects associated with fingolimod and other S1P receptor modulators. Amiselimod-P shows potent and high selectivity for S1P1 and S1P5 but with minimal agonist activity for S1P4 and no distinct agonist activity for S1P2 or S1P3. Amiselimod hydrochloride is promising for research of autoimmune diseases .

Cat. No.	Product Name	Type

HY-116282

Dextran sulfate sodium salt (MW 5000)

2 Publications Verification

DSS (MW 5000); DXS (MW 5000)

Carbohydrates

Dextran sulfate sodium salt (MW 5000) is a polymer of anhydroglucose with a molecular weight of 5000. Dextran sulfate sodium salt (MW 5000) can be used to induce acute colitis and cause apoptosis of colonic epithelial cells in mice. The concentration dose used in the study was 5% (in feed, w/w). The sulfated polysaccharide dextran sulfate is also an effective inhibitor of HIV. Dextran sulfate sodium salt (MW 5000) can significantly inhibit HIV-1 replication at a concentration that does not significantly inhibit the blood coagulation process. Dextran sulfate sodium salt (MW 5000) protects MT-4 cells from HIV-1-induced cellular pathogenicity. Dextran sulfate-induced colitis can be inhibited by Puerarin (HY-N0145), Baicalein (HY-N0196), β-Caryophyllene (HY-N1415).

Cat. No.	Product Name	Target	Research Area

HY-N2466

Melanotan I 1 Publications Verification MT-I; [Nle4,D-Phe7]-α-MSH	Melanocortin Receptor	Neurological Disease Cancer
Melanotan I is a potent non-selective melanocortin receptor (MCR) agonist. Melanotan I is a synthetic analogue of α-melanocyte stimulating hormone (α-MSH) that stimulates melanogenesis. Melanotan I can induce skin tanning by mimicking the actions of a-MSH on the melanocortin type 1 receptors (MC1R) of melanocytes. Melanotan I can be used for the research of sun-induced skin cancer, melanoma, inflammation and male erectile dysfunction .

HY-P0267

Melanotan (MT)-II	Peptides	Neurological Disease
Melanotan (MT)-II, a synthetic melanocortin receptor agonist, is an injectable peptide hormone used to promote tanning.

HY-P4931

Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2	MMP	Cancer
Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 (FS-6) is a fluorescent peptide that is a quenched MMP peptide substrate. Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 can be used for real-time quantification of MMP enzymatic activity. Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 is an elongated peptide of MMP substrate (FS-1) and is active against collagenases (MMP-1, MMP-8, MMP-13 ) and MT1-MMP with higher specificity constants than FS-1 . (Ex/Em=325 nm/400 nm)

HY-P5846

Muscarinic toxin 3 MT3	mAChR Adrenergic Receptor	Neurological Disease
Muscarinic toxin 3 (MT3) is a potent and non-competitive mAChR and adrenoceptors antagonist with pIC₅₀s of 6.71, 8.79, 8.86, 7.57, 8.13, 8.49, <6.5, 7.29 against M₁, M₄, α_1A, α_1B, α_1D,α_2A,α_2B and α_2C receptors, respectively. Muscarinic toxin 3 displays prominent adrenoceptor activity .

HY-N2466A

Melanotan I acetate MT-I acetate; [Nle4,D-Phe7]-α-MSH acetate	Melanocortin Receptor	Cancer
Melanotan I acetate is a potent non-selective melanocortin receptor (MCR) agonist. Melanotan I acetate is a synthetic analogue of α-melanocyte stimulating hormone (α-MSH) that stimulates melanogenesis. Melanotan I acetate can induce skin tanning by mimicking the actions of a-MSH on the melanocortin type 1 receptors (MC1R) of melanocytes. Melanotan I acetate can be used for sunlight-induced skin cancers research .

HY-P10407

BM30	DNA Methyltransferase	Cancer
BM30 is a selective peptidomimetic NTMT1 and NTMT2 inhibitor (IC₅₀: 0.89 μM for NTMT1) .

HY-P10621

SHLP-1	Peptides	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
SHLP-1 is a mitochondrial-derived peptide, a biologically active microprotein encoded by the 16S ribosomal RNA (MT-RNR2) gene. SHLP-1 can be used in the research of diabetes, Alzheimer's disease, cardiovascular disease and prostate cancer .

HY-P10624

SHLP-5	Peptides	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
SHLP-5 is a mitochondrial-derived peptide, a biologically active microprotein encoded by the 16s ribosomal RNA (MT-RNR2) gene. SHLP-5 can be used in the research of diabetes, Alzheimer's disease, cardiovascular disease and prostate cancer .

HY-P10623

SHLP-4	Peptides	Cardiovascular Disease Metabolic Disease
SHLP-4 is a mitochondrial derived peptide, a biologically active microprotein encoded by the 16S ribosomal RNA (MT-RNR2) gene. SHLP-4 increases the proliferation of mouse NIT-1 cells. SHLP-4 can be used in the study of diabetes and cardiovascular diseases .

HY-P10625

SHLP-6	Apoptosis	Metabolic Disease Cancer
SHLP-6 is a mitochondrial-derived peptide, a biologically active microprotein encoded by the 16S ribosomal RNA (MT-RNR2) gene. SHLP6 increases apoptosis in insulinoma cells NIT1 and human prostate cancer cell 22Rv1. SHLP6 can be used in the study of diabetes and cancer .

HY-P10622

SHLP-3	Apoptosis Reactive Oxygen Species	Metabolic Disease Cancer
SHLP-3 is a mitochondrial derived peptide encoded by the 16S ribosomal RNA (MT-RNR2) gene. SHLP-3 increases cell viability and reduces apoptosis in insulinoma NIT-1β cells and human prostate cancer 22Rv1 cells. SHLP-3 increases mitochondrial function and exerts cytoprotective effects by increasing mitochondrial oxygen consumption rate (OCR), cellular ATP and reducing the ability to produce ROS. SHLP-3 can be used in the study of diabetes and cancer .

Cat. No.	Product Name	Target	Research Area

HY-P99959

Unasnemab MT-3921; rH116A3	Inhibitory Antibodies	Neurological Disease
Unasnemab (MT-3921) is a humanised IgG1 monoclonal antibody that binds to repulsive guidance molecule A (RGMa). Unasnemab improves locomotor function and promotes neuroregeneration and can be used for the research of spinal cord injury .

HY-P99278

Adecatumumab MT 201; Anti-Human EPCAM Recombinant Antibody	Inhibitory Antibodies	Cancer
Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status .

HY-P99592

Solitomab AMG 110; MT110	CD3	Cancer
Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM) antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-17038

Agomelatine 4 Publications Verification S-20098	Structural Classification Alkaloids Neurological Disease Classification of Application Fields Other Alkaloids Source classification Endogenous metabolite Disease Research Fields	Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine (S-20098) is a specific agonist of *MT1* and *MT2* receptors with K_is of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine is a selective 5-HT2C receptor antagonist with pK_is of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-17038A

Agomelatine hydrochloride 4 Publications Verification S-20098 hydrochloride	Structural Classification Alkaloids Neurological Disease Classification of Application Fields Other Alkaloids Source classification Endogenous metabolite Disease Research Fields	Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine hydrochloride (S-20098 hydrochloride) is a specific agonist of *MT1* and *MT2* receptors with K_is of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine hydrochloride is a selective 5-HT2C receptor antagonist with pK_is of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-17038B

Agomelatine (L(+)-Tartaric acid) 4 Publications Verification S-20098 L(+)-Tartaric acid	Structural Classification Alkaloids Neurological Disease Classification of Application Fields Other Alkaloids Source classification Endogenous metabolite Disease Research Fields	Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of *MT1* and *MT2* receptors with K_is of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pK_is of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-N12260

Benanomicin A	Quinones Structural Classification Microorganisms Anthraquinones Source classification	HIV Bacterial
Benanomicin A is a microbial metabolite and can be isolated from Actinomycetes.Benanomicin has antifungal activitya and inhibits HIV-1 viral infection in MT-4 cells .

HY-137309

4-Deoxy-4α-phorbol	Structural Classification Terpenoids Source classification Euphorbia cooperi N. E. Br. ex A. Berger Diterpenoids Euphorbiaceae Plants	HIV
4-Deoxy-4α-phorbol is a tetracyclic diterpene found in E. desmondi. It has been used in the semisynthesis of inhibitors of the HIV-1-induced cytopathic effect on MT-4 cells and 4α-phorbol esters .

HY-N11288

Methyl salvionolate A	Structural Classification Labiatae Source classification Phenols Polyphenols Salvia yunnanensis C. H. Wright Plants	HIV
Methyl salvionolate A is a potent inhibitor of HIV-1. Methyl salvionolate A inhibits P24 antigen in HIV-1 infected MT-4 cell with an EC₅₀ of 1.62 μg/ml. Methyl salvionolate A also inhibits HIV-1 reverse transcriptase, protease and integrase with IC₅₀s of 50.58, 10.73 and 7.58 μg/ml, respectively .

HY-17038R

Agomelatine (Standard)	Structural Classification Alkaloids Other Alkaloids Source classification Endogenous metabolite	Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine (Standard) is the analytical standard of Agomelatine. This product is intended for research and analytical applications. Agomelatine (S-20098) is a specific agonist of *MT1* and *MT2* receptors with K_is of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine is a selective 5-HT2C receptor antagonist with pK_is of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-N0086R

N6-Methyladenosine (Standard)	Structural Classification Natural Products Microorganisms Source classification Endogenous metabolite	Influenza Virus Endogenous Metabolite
N6-Methyladenosine (Standard) is the analytical standard of N6-Methyladenosine. This product is intended for research and analytical applications. N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities. In Vitro: N6-methyladenosine (m6A) is selectively recognized by the human YTH domain family 2 (YTHDF2) protein to regulate mRNA degradation. N6-methyladenosine (m6A), a prevalent internal modification in the messenger RNA of all eukaryotes, is post-transcriptionally installed by m6A methyltransferase (e.g., MT-A70) within the consensus sequence of G(m6A)C (70%) or A(m6A)C (30%). N6-methyladenosine (m6A)-containing RNAs are greatly enriched in the YTHDF-bound portion and diminished in the flow-through portion . N6-methyladenosine (m6A), the most abundant internal RNA modification, functions in diverse biological processes, including regulation of embryonic stem cell self-renewal and differentiation. N6-methyladenosine (m6A) is a large protein complex, consisting in part of methyltransferase-like 3 (METTL3) and methyltransferase-like 14 (METTL14) catalytic subunits .

Species:	Human (10) Mouse (5)
Tag:	His (13) SUMO (1) Tag Free (1) Myc (1) GST (2) Flag (1) Fc (3)
Source:	HEK293 (5) Sf9 insect cells (1) Sf9 insect cells (4) E. coli (8)

Cat. No.	Compare	Product Name	Species	Source

HY-P79097

	MMP-16 Protein, Human (I152N, His) Matrix metalloproteinase-16; MMP16; MMP-16; MMP-X2; Membrane-type matrix metalloproteinase 3; MT-MMP 3; MTMMP3; Membrane-type-3 matrix metalloproteinase; MT3-MMP; MT3MMP; C8orf57; MMPX2; Matrix Metalloproteinase 16/Membrane Type 3 MMP	Human	E. coli
	The MMP-16 protein functions as an endopeptidase capable of degrading various components of the extracellular matrix, particularly type III collagen and fibronectin. Its effects extend to the activation of progelatinase A, which contributes to the dynamic remodeling of the extracellular matrix within blood vessels. MMP-16 Protein, Human (I152N, His) is the recombinant human-derived MMP-16 protein, expressed by E. coli , with C-10*His labeled tag. The total length of MMP-16 Protein, Human (I152N, His) is 260 a.a, with molecular weight of ~29 kDa.

HY-P76256

	CHODL Protein, Mouse (HEK293, His) Chondrolectin; Transmembrane protein MT75; C21orf68	Mouse	HEK293
	CHODL proteins contribute significantly to nervous system development, particularly in neurite growth and elongation. There is evidence that it is involved in guiding motor axon growth and shaping the structural framework of the nervous system. CHODL Protein, Mouse (HEK293, His) is the recombinant mouse-derived CHODL protein, expressed by HEK293 , with C-His labeled tag.

HY-P71393

	TXN2 Protein, Human (His) Thioredoxin Mitochondrial; MTRX; MT-Trx; Thioredoxin-2; TXN2; TRX2	Human	E. coli
	As a monomer, the TXN2 protein is critical for maintaining mitochondrial reactive oxygen species (ROS) homeostasis, regulating apoptosis, and ensuring cell viability.Its unique dithiol reducing activity fine-tunes cellular redox balance, making a significant contribution to overall cellular health.TXN2 Protein, Human (His) is the recombinant human-derived TXN2 protein, expressed by E.coli , with tag free.

HY-P703481

	MT-RNR1 Protein, Human (His, GST) Mitochondrial-derived peptide MOTS-c; Mitochondrial open reading frame of the 12S rRNA-c; MT-RNR1; Homo sapiens; Human; DNA-binding	Human	E. coli
	MT-RNR1 Protein, Human (His, GST) is the recombinant human-derived MT-RNR1, expressed by E. coli , with His, GST labeled tag. ,

HY-P703929

	CCR5 Protein, Human (Sf9, Flag-His) GRP75; HSPA9B; MT-HSP70	Human	Sf9 insect cells

HY-P702943

	HSPA9 protein, Human (sf9, GST) GRP75; HSPA9B; MT-HSP70; Mortalin Protein	Human	Sf9 insect cells
	HSPA9 protein, Human (sf9, GST) is the recombinant human-derived HSPA9, expressed by Sf9 insect cells , with GST labeled tag. The total length of HSPA9 protein, Human (sf9, GST) is 633 a.a.,

HY-P77090

	MRPL44 Protein, Human (sf9, His) 39S ribosomal protein L44, mitochondrial; L44MT; MRP-L44	Human	Sf9 insect cells
	MRPL44 protein is an important component of the 39S subunit of mitochondrial ribosomes. MRPL44 Protein, Human (sf9, His) is the recombinant human-derived MRPL44 protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of MRPL44 Protein, Human (sf9, His) is 332 a.a., with molecular weight of ~40 kDa.

HY-P77897

	CHODL Protein, Human (HEK293, Fc) Chondrolectin; CHODL; C21orf68; 3110074E07Rik; MT75; PRED12; FLJ12627	Human	HEK293
	CHODL protein contributes to nervous system development, affecting neurite outgrowth and motor axon growth. Interacting with RABGGTB, it plays a crucial role in cellular processes and neural circuit establishment. Investigating CHODL's mechanisms and effects in neurite outgrowth and motor axon growth can offer insights into its role in shaping the developing nervous system. CHODL Protein, Human (HEK293, Fc) is the recombinant human-derived CHODL protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P78270

	CHODL Protein, Mouse (HEK293, Fc) Chondrolectin; CHODL; C21orf68; 3110074E07Rik; MT75; PRED12; FLJ12627	Mouse	HEK293
	CHODL proteins contribute significantly to nervous system development, particularly in neurite growth and elongation. There is evidence that it is involved in guiding motor axon growth and shaping the structural framework of the nervous system. CHODL Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived CHODL protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P71166

	NOTCH1 Protein, Mouse (HEK293, His) Neurogenic locus notch homolog protein 1; Notch 1; Motch A; MT14	Mouse	HEK293
	NOTCH1 Protein acts as a receptor for membrane-bound ligands (JAG1, JAG2, and DLL1), determining cell fate.Upon activation, NICD forms a transcriptional activator complex, influencing differentiation, proliferation, and apoptosis.NOTCH1 negatively regulates angiogenesis, endothelial cell behavior, and impacts various developmental processes.It interacts with multiple partners, illustrating its involvement in signaling networks.NOTCH1 Protein, Mouse (HEK293, His) is the recombinant mouse-derived NOTCH1 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P73324

	NOTCH1 Protein, Mouse (sf9, His) Neurogenic locus notch homolog protein 1; Notch 1; Motch A; MT14	Mouse	Sf9 insect cells
	NOTCH1 Protein acts as a receptor for membrane-bound ligands (JAG1, JAG2, and DLL1), determining cell fate.Upon activation, NICD forms a transcriptional activator complex, influencing differentiation, proliferation, and apoptosis.NOTCH1 negatively regulates angiogenesis, endothelial cell behavior, and impacts various developmental processes.It interacts with multiple partners, illustrating its involvement in signaling networks.NOTCH1 Protein, Mouse (sf9, His) is the recombinant mouse-derived NOTCH1 protein, expressed by Sf9 insect cells , with C-His labeled tag.

HY-P73742

	NOTCH1 Protein, Human (HEK293, Fc) Neurogenic locus notch homolog protein 1; Notch 1; Motch A; MT14	Human	HEK293
	NOTCH1 protein is a receptor for the ligands JAG1, JAG2 and DLL1 and is critical for cell fate decisions. Upon ligand activation, NICD forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes in the cleavage site enhancer. NOTCH1 Protein, Human (HEK293, Fc) is the recombinant human-derived NOTCH1 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of NOTCH1 Protein, Human (HEK293, Fc) is 508 a.a., with molecular weight of ~79.7 kDa.

HY-P702797

	EsxB Protein, Mycobacterium tuberculosis (His) esxB; cfp10; lhp; MTsA10; MT3988ESAT-6-like protein EsxB; 10 kDa culture filtrate antigen CFP-10; Secreted antigenic protein MTSA-10	Others	E. coli

HY-P702605

	CFP-10 Protein, Mycobacterium tuberculosis (His) esxB; cfp10; lhp; MTsA10; MT3988ESAT-6-like protein EsxB; 10 kDa culture filtrate antigen CFP-10; Secreted antigenic protein MTSA-10; Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	Others	E. coli
	CFP-10 Protein, Mycobacterium tuberculosis (His) is the recombinant CFP-10, expressed by E. coli , with N-6*His labeled tag. The total length of CFP-10 Protein, Mycobacterium tuberculosis (His) is 99 a.a., .

HY-P72049

	CYP51 Protein, Mycobacterium tuberculosis (sf9, His-Myc) cyp51; MT0788Lanosterol 14-alpha demethylase; EC 1.14.14.154; CYPLI; Cytochrome P450 51; Cytochrome P450-14DM; Cytochrome P450-LIA1; Sterol 14-alpha demethylase	Others	Sf9 insect cells
	CYP51 Proteinas is a sterol 14α-demethylase that acts with an unknown physiological substrate and accepts electrons from the iron-sulfur ferredoxin Fdx. In vitro, it catalyzes the C14-demethylation of lanosterol, 24,25-dihydrolanosterol, and obtanyol, showing stereoselectivity in producing 8,14-diene. CYP51 Protein, Mycobacterium tuberculosis (sf9, His-Myc) is the recombinant CYP51 protein, expressed by Sf9 insect cells , with N-10*His, C-Myc labeled tag.

HY-P700007

	MMP-14 Protein, Human (His-SUMO) Matrix metalloproteinase 14 ; Matrix metalloproteinase-14; Membrane type 1 matrix metalloproteinase ; Membrane type 1 metalloprotease; Membrane type matrix metalloproteinase 1; Membrane-type-1 matrix metalloproteinase; MMP 14; MMP X1; MMP-14; MMP-X1; Mmp14; MMP14_HUMAN; MMPX1; MT MMP 1	Human	E. coli
	MMP-14 protein is an endopeptidase that degrades collagen and activates progelatinase A. MMP-14 Protein, Human (His-SUMO) is the recombinant human-derived MMP-14 protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag. The total length of MMP-14 Protein, Human (His-SUMO) is 471 a.a., with molecular weight of ~69.9 KDa.

HY-P702524

	Matriptase/ST14 Catalytic Domain Protein, Mouse (His) EC 3.4.21; Epithin; HAI; Matriptase; Membrane-type serine protease 1; MTSP1; MT-SP1EC 3.4.21.109; prostamin; PRSS14; Serine protease 14; Serine protease TADG-15; SNC19; SNC19MTSP1; ST14; suppressor of tumorigenicity 14 protein; TADG15; TADG-15; TMPRSS14; tumor associated differentially expressed gene 15 protein; Tumor-associated differentially-expressed gene 15 protein	Mouse	E. coli
	The Matriptase/ST14 catalytic domain protein exhibits serine-type endopeptidase activity and is critical in processes as diverse as placental branching and neural tube closure. It is an extrinsic component of the plasma membrane and is expressed in structures such as the digestive system, early concepts, genitourinary system, pituitary gland, and sense organs. Matriptase/ST14 Catalytic Domain Protein, Mouse (His) is the recombinant mouse-derived Matriptase/ST14 Catalytic Domain protein, expressed by E. coli , with N-6*His labeled tag.

HY-P702523

	Matriptase/ST14 Catalytic Domain Protein, Human (His) EC 3.4.21; Epithin; HAI; Matriptase; Membrane-type serine protease 1; MTSP1; MT-SP1EC 3.4.21.109; prostamin; PRSS14; Serine protease 14; Serine protease TADG-15; SNC19; SNC19MTSP1; ST14; suppressor of tumorigenicity 14 protein; TADG15; TADG-15; TMPRSS14; tumor associated differentially expressed gene 15 protein; Tumor-associated differentially-expressed gene 15 protein	Human	E. coli
	The Matriptase/ST14 catalytic domain protein originates from epithelial cells, forms a complex with HAI-1, and is activated by sphingosine-1-phosphate. It cleaves and activates hepatocyte growth factor/scatter factor and urokinase plasminogen activator, suggesting its role as an activator of other proteases and potential growth factors. Matriptase/ST14 Catalytic Domain Protein, Human (His) is the recombinant human-derived Matriptase/ST14 Catalytic Domain protein, expressed by E. coli , with N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-17038S

Agomelatine-d6
Agomelatine-d₆ is deuterium labeled Agomelatine. Agomelatine is a specific agonist of MT1 and MT2 receptors[1] .

HY-103005S

Ramelteon metabolite M-II-d3
Ramelteon metabolite M-II-d₃ is the deuterium labeled Ramelteon metabolite M-II. Ramelteon metabolite M-II is the major metabolite of Ramelteon, with IC50s of 208 pM, 1470 pM for human melatonin receptors (MT1 or MT2). Ramelteon is a selective melatonin agonist[1][2].

HY-B0439S1

Sulfadoxine D3

Sulfadoxine-d₃ is a deuterium labeled Sulfadoxine (HY-B0439). Sulfadoxine is a sulfonamide that is used, usually in combination with Pyrimethamine (HY-18062), for multidrug-resistant Plasmodium falciparum and P. vivax inhibition. Unlike PYR, Sulfadoxine has no impact on HIV replication or MT-2 cell cycle progression. But also Sulfadoxine exhibits suppression on respiratory, and urinary tract infections[1][2][3][4].

HY-17038S2

Agomelatine-d3
Agomelatine-d₃ is the deuterium labeled Agomelatine. Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].

HY-A0014S

Ramelteon-d5

Ramelteon-d₅ is deuterium labeled Ramelteon. Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation[1][2].

HY-14803S

Tasimelteon-d5
Tasimelteon-d₅ is the deuterium labeled Tasimelteon. Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24)[1][2].

HY-17038S1

Agomelatine-d4
Agomelatine-d₄ is the deuterium labeled Agomelatine. Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81119

	MTNR1A Antibody MTR1A_HUMAN; Melatonin receptor type 1A; Melatonin Receptor 1A; Mel-1A-R; Mel1a receptor; MT1; MT 1; Mel 1A R	WB, ELISA, IHC-P, IHC-F, ICC/IF	Human, Mouse, Rat
	MTNR1A Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-MTNR1A polyclonal antibody. MTNR1A Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep, guinea pig background without labeling.

HY-P82344

	MT ND1 Antibody (YA2089) MT-ND1; MTND1; NADH1; ND1; NADH-ubiquinone oxidoreductase chain 1; NADH dehydrogenase subunit 1	WB	Human, Mouse, Rat
	MT ND1 Antibody (YA2089) is a biotin-conjugated non-conjugated IgG antibody, targeting MT ND1, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). MT ND1 Antibody (YA2089) can be used for WB experiment in human, mouse, rat background.

HY-P83509

	MTCO2 Antibody (YA3254) MT-CO2; COX2; CO2; Cytochrome c oxidase II; MTCO2; COII; COXII	WB, IHC-F, IHC-P, ICC/IF, IP	Human
	MTCO2 Antibody (YA3254) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3254), targeting MTCO2, with a predicted molecular weight of 26 kDa (observed band size: 21 kDa). MTCO2 Antibody (YA3254) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.

HY-P81845

	MMP14 Antibody (YA1590) MMP-14; MMP-X1; MT-MMP; MT1MMP; MTMMP1; WNCHRS; MT1-MMP; MT-MMP 1	WB, IHC-P, IP	Human, Hamster
	MMP14 Antibody (YA1590) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1590), targeting MMP14, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). MMP14 Antibody (YA1590) can be used for WB, IHC-P, IP experiment in human, hamster background.

HY-P81983

	MMP17 Antibody (YA1728) MMP17; MT4MMP; Matrix metalloproteinase-17; MMP-17; Membrane-type matrix metalloproteinase 4; MT-MMP 4; MTMMP4; Membrane-type-4 matrix metalloproteinase; MT4-MMP; MT4MMP	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	MMP17 Antibody (YA1728) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1728), targeting MMP17, with a predicted molecular weight of 67 kDa (observed band size: 58 kDa). MMP17 Antibody (YA1728) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.

HY-P83501

	MRPS31 Antibody (YA3246) S31MT; IMOGN38; MRP-S31	WB	Rat
	MRPS31 Antibody (YA3246) is a biotin-conjugated non-conjugated IgG antibody, targeting MRPS31, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). MRPS31 Antibody (YA3246) can be used for WB experiment in rat background.

HY-P82447

	Thioredoxin 2 Antibody (YA2192) TXN; MTRX; TRX2; MT-TRX; COXPD29	WB, IHC-F, IHC-P, ICC/IF	Human, Mouse, Rat
	Thioredoxin 2 Antibody (YA2192) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2192), targeting Thioredoxin 2, with a predicted molecular weight of 18 kDa (observed band size: 13 kDa). Thioredoxin 2 Antibody (YA2192) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.

HY-P83485

	Mitochondrial Ribosomal Protein L11 Antibody (YA3230) MRPL11; CGI-113; 39S ribosomal protein L11; mitochondrial; L11MT; MRP-L11	WB, IHC-F, IHC-P, ICC/IF	Human
	Mitochondrial Ribosomal Protein L11 Antibody (YA3230) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3230), targeting Mitochondrial Ribosomal Protein L11, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). Mitochondrial Ribosomal Protein L11 Antibody (YA3230) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.